SYFOVRE

Drug Apellis Pharmaceuticals, Inc.
Total Payments
$106,869
Transactions
78
Doctors
41
Companies
1

Payment Trends by Year

Year Amount Transactions Doctors
2023 $106,869 78 41

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $106,438 63 99.6%
Food and Beverage $356.09 12 0.3%
Travel and Lodging $74.18 3 0.1%

Top Doctors Receiving Payments for SYFOVRE — Page 2

Doctor Specialty Location Total Records
, OD Optometrist San Antonio, TX $1,419 3
, OD Optometrist Indianapolis, IN $1,243 1
, O.D Optometrist Fort Lauderdale, FL $1,183 2
, M.D Ophthalmology Cleveland, OH $1,086 1
, MD Retina Specialist Milwaukee, WI $1,086 1
, O.D Optometrist Bowling Green, OH $982.50 2
, M.D Ophthalmology Norfolk, VA $834.00 2
, MD Ophthalmology Richmond, VA $756.00 1
, OD Optometrist Bradenton, FL $622.00 1
, M.D Ophthalmology Lexington, KY $473.00 1
, M.D Ophthalmology Bradenton, FL $378.00 1
, MD Retina Specialist Silverdale, WA $288.50 1
, MD Ophthalmology Walnut Creek, CA $203.60 5
, MD, PHD Retina Specialist Bellaire, TX $99.92 4
, MD Ophthalmology Cleveland, OH $77.94 4
, MD Specialist Boston, MA $48.81 2

About SYFOVRE

SYFOVRE is a drug associated with $106,869 in payments to 41 healthcare providers, recorded across 78 transactions in the CMS Open Payments database. The primary manufacturer is Apellis Pharmaceuticals, Inc..

Payment data is available from 2023 to 2023. In 2023, $106,869 was paid across 78 transactions to 41 doctors.

The most common payment nature for SYFOVRE is "Consulting Fee" ($106,438, 99.6% of total).